A 52-year-old man with chronic kidney disease (eGFR 25 mL/min/1.73m²) is started on a new drug. The clinician suspects the drug may accumulate due to renal impairment. Which investigation is most appropriate to assess whether the drug undergoes significant renal elimination and to guide dosing adjustments?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.